semaglutide consent form Contact Us Now Weight Loss Injection Intake Questionnaire
Description
Most telehealth GLP-1 programs require a BMI of 27 or higher with a weight-related health condition, or a BMI of 30 or higher without comorbidities, consistent with FDA labeling for chronic weight management
Its not merely a theoretical risk either, as clinical trial and real-world use reports highlight several particular side effects
Its important to let your doctor know about any side effects you experience and if they change or get worse
General and Comparative Endocrinology, 270, 7581
The question of whether to combine phentermine with GLP-1 compounds is particularly relevant here
